Shaping the Future of Medicine and
Improving the Health of Hawaii’s people
The Queen’s Center for Biomedical Research is hosting Dr. Christine Peinelt during her sabbatical leave of absence from her position as Professor and Principal Investigator at the Institute of Biochemistry and Molecular Medicine (IBBM), University of Bern, Switzerland. Dr. Peinelt spent her postdoctoral years at QCBR
The Queen’s Center for Biomedical Research is hosting Dr. Christine Peinelt during her sabbatical leave of absence from her position as Professor and Principal Investigator
Dr. Suzuki’s study demonstrates that CBGA, and to a lesser extent CBD, can protect the kidney from damage that can arise acutely as a side-effect
Dr. Fleig and her multi-disciplinary collaborative team were awarded a multi-year NIH grant through the NINDS IGNITE program. IGNITE stands for “Innovation Grants to Nurture
Dr. Ortega’s study investigates a unique Exoc5 conditional knockout mouse that develops obstruction of the urinary tract during embryo development. This blockage causes an accumulation
Dr. Faouzi’s study reports for the first time that several minor cannabinoids, mainly the carboxylic acid derivatives and particularly cannabigerolic acid (CBGA), demonstrated high potency
The LEADS Nashville Summit was organized by the University of Pittsburgh between March 23 and 25, 2022.
Provost Bruno, Reinhold Penner, President Lassner, Regent Haning III
1356 Lusitana St. UH Tower 8, Honolulu, HI 96813